![Ronald Cohen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ronald Cohen
Directeur Général chez
Civitas Therapeutics, Inc.
Profil
Ronald Cohen was the founder of Acorda Therapeutics, Inc., founded in 1995, where the title held was President, Chief Executive Officer & Director from 2021 to 2024.
Current jobs include Chief Executive Officer at Civitas Therapeutics, Inc., President, Chief Executive Officer & Director at Acorda Therapeutics Ltd., Chief Executive Officer at Oryon Cell Therapies, Inc., and Director at Biotechnology Innovation Organization since 2017.
Former jobs include Chairman at New York Biotechnology Association, Inc., Chairman at Biotie Therapies Oy, Independent Director at Dyax Corp.
from 2011 to 2016, Independent Non-Executive Director at Vascular Biogenics Ltd. from 2015 to 2022, and Principal at Advanced Tissue Sciences, Inc. from 1986 to 1992.
Education includes undergraduate studies at Princeton University and a doctorate from Columbia University College of Physicians & Surgeons.
Postes actifs de Ronald Cohen
| Sociétés | Poste | Début |
|---|---|---|
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Directeur/Membre du Conseil | 19/06/2017 |
Acorda Therapeutics Ltd.
 Acorda Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutic products for nervous system disorders | Directeur Général | - |
Civitas Therapeutics, Inc.
 Civitas Therapeutics, Inc. BiotechnologyHealth Technology Develops transformative pulmonary delivery therapies | Directeur Général | - |
Anciens postes connus de Ronald Cohen
| Sociétés | Poste | Fin |
|---|---|---|
| ACORDA THERAPEUTICS, INC. | Directeur Général | 21/08/2024 |
| NOTABLE LABS, LTD. | Directeur/Membre du Conseil | 01/08/2022 |
| DYAX CORP. | Directeur/Membre du Conseil | 22/01/2016 |
Advanced Tissue Sciences, Inc.
 Advanced Tissue Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops human-based tissue products for therapeutic applications | Corporate Officer/Principal | 01/01/1992 |
| BIOTIE THERAPIES CORP | Président | - |
Formation de Ronald Cohen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
62
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Advanced Tissue Sciences, Inc.
Advanced Tissue Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops human-based tissue products for therapeutic applications | Commercial Services |
Dyax Corp.
 Dyax Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of novel biotherapeutics | Health Technology |
Acorda Therapeutics, Inc.
 Acorda Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops neurology therapies | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Biotie Therapies Oy
 Biotie Therapies Oy Pharmaceuticals: MajorHealth Technology Engages in research, development and commercialization of pharmaceutical products | Health Technology |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York Biotechnology Association, Inc.
 New York Biotechnology Association, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as an association that promotes the biotechnology industry | Commercial Services |
Vascular Biogenics Ltd.
 Vascular Biogenics Ltd. BiotechnologyHealth Technology Develops novel treatments for atherosclerosis and cancer | Health Technology |
Civitas Therapeutics, Inc.
Civitas Therapeutics, Inc. BiotechnologyHealth Technology Develops transformative pulmonary delivery therapies | Health Technology |
Columbia University College of Physicians & Surgeons
 Columbia University College of Physicians & Surgeons Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Acorda Therapeutics Ltd.
Acorda Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutic products for nervous system disorders | Health Technology |
Choisissez Zonebourse 
